---
title: "YONGAN PHARMACEUTICAL: There are no significant matters related to the company that should be disclosed but have not been disclosed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243853693.md"
description: "YONGAN PHARMACEUTICAL issued a notice of unusual movement, stating that the company's recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment; the company, its controlling shareholders, and actual controllers do not have any significant matters related to the company that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage"
datetime: "2025-06-10T09:15:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243853693.md)
  - [en](https://longbridge.com/en/news/243853693.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243853693.md)
generator: "portal-rs"
---

# YONGAN PHARMACEUTICAL: There are no significant matters related to the company that should be disclosed but have not been disclosed

YONGAN PHARMACEUTICAL issued a notice of unusual movement, stating that the company's recent operating conditions are normal and there have been no significant changes in the internal and external operating environment; the company, its controlling shareholders, and actual controllers do not have any significant matters related to the company that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage

### Related Stocks

- [002365.CN](https://longbridge.com/en/quote/002365.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)
- [Qualicorp releases 2Q26 institutional presentation factsheet](https://longbridge.com/en/news/296404030.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [13:22 ET/C O R R E C T I O N -- Rayence/](https://longbridge.com/en/news/296256530.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**